DePuy Synthes Acquires CUPTIMIZE™ Hip-Spine Analysis, Providing Technology to Help Surgeons Better Understand, Measure and Address Pelvic Tilt

Newest Addition to VELYS™ Digital Surgical procedure Platform, CUPTIMIZE™ Hip-Backbone Evaluation is a Easy, X-Ray-Primarily based Digital Answer that makes use of patient-specific information to assist surgeons assess dislocation threat, with the purpose of enhancing outcomes 

Used with DePuy Synthes’ hip implants, this know-how goals to ship a complete procedural answer to advance affected person outcomes

Palm Seaside Gardens, FL. – March 21, 2022 – Right now, Johnson & Johnson MedTech* introduced that DePuy Synthes,** The Orthopaedics Firm of Johnson & Johnson, has acquired CUPTIMIZE™ Hip-Backbone Evaluation, giving surgeons an easy-to-use software to higher perceive and tackle the influence of irregular movement between the backbone and pelvis in some sufferers who require whole hip arthroplasty (THA). CUPTIMIZE Hip-Backbone Evaluation (CUPTIMIZE Evaluation) enhances the surgical planning capabilities of VELYS™ Hip Navigation, one of many options inside DePuy Synthes’ VELYS Digital Surgical procedure platform of linked applied sciences.

Irregular pelvic tilt is current in roughly 20 p.c of sufferers who require whole hip arthroplasty.¹ It’s estimated that as much as 50 p.c of revision THAs are avoidable and of these, 48 p.c are because of suboptimal cup positioning.² A hip-spine evaluation that allows the surgeon to quantify modifications in pelvic tilt could present for optimum cup positioning which can assist cut back the danger of dislocation associated to pelvic tilt.³

In contrast to different applied sciences, CUPTIMIZE Hip-Backbone Evaluation doesn’t depend on superior imaging or engineering workers. As an alternative, a easy, digital screening software analyzes x-rays of the affected person when standing and sitting to determine irregular movement between a affected person’s backbone and pelvis (e.g., pelvic tilt). Together with VELYS Hip Navigation’s intra-operative capabilities, CUPTIMIZE permits surgeons to ship extra customized care.

“The CUPTIMIZE Evaluation is simple to make use of and permits me to make pre-operative selections relating to a affected person’s distinctive spinopelvic traits in a easy manner earlier than surgical procedure,” stated Dr. Jonathan Vigdorchik,*** orthopaedic surgeon, New York, NY. “It’s an environment friendly software to execute my plan through the operation.” 

VELYS Hip Navigation supplies an built-in answer for pre-operative planning and intra-operative execution that gives actionable, real-time information to personalize hip alternative and is designed to enhance precision, enhance surgical reproducibility, and optimize affected person outcomes.

“At DePuy Synthes, we’re centered on addressing unmet wants with superior applied sciences to ship probably the most customized care, like VELYS Hip Navigation with the CUPTIMIZE Evaluation, with the objective of higher outcomes for joint alternative surgical procedure sufferers,” stated Sharrolyn Josse,**** Worldwide President, VELYS Digital Surgical procedure & Capital “This acquisition is yet one more development on our journey to turning into probably the most customized and linked orthopaedics firm.”

For extra info on VELYS Hip Navigation and different enabling applied sciences from DePuy Synthes, go to right here.   

About Johnson & Johnson MedTech
At Johnson & Johnson MedTech, we unleash various healthcare experience, purposeful know-how, and a ardour for individuals to remodel the way forward for medical intervention and empower everybody to reside their finest life potential. For greater than a century, we’ve got pushed breakthrough scientific innovation to handle unmet wants and reimagine well being. In surgical procedure, orthopaedics, imaginative and prescient, and interventional options, we proceed to assist save lives and create a future the place healthcare options are smarter, much less invasive, and extra customized.

About DePuy Synthes 
DePuy Synthes, The Orthopaedics Firm of Johnson & Johnson, supplies one of the complete orthopaedics portfolios on this planet that helps heal and restore motion for the thousands and thousands of sufferers we serve. DePuy Synthes options, in specialties together with joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgical procedure and sports activities drugs, along with the VELYS™ Digital Surgical procedure portfolio, are designed to advance affected person care whereas delivering medical and financial worth to healthcare methods worldwide. Constructing on our proud product innovation and legacy of business firsts, we’re re-imagining the orthopaedic panorama with new developments in medical applied sciences and digital surgical procedure throughout the whole continuum of care to Preserve Individuals Transferring immediately and tomorrow. For extra info, go to www.depuysynthes.com. 

Media Contact: 
Monika Schoenbeck
Mschoen6@its.jnj.com

* Comprising the surgical procedure, orthopaedics, imaginative and prescient and interventional options companies inside Johnson & Johnson’s MedTech section. 
** DePuy Synthes represents the services of DePuy Synthes Gross sales, Inc., and its associates.
*** Dr. Jonathan Vigdorchik is a design surgeon and a paid marketing consultant of an affiliate of DePuy Synthes.  
**** Sharrolyn Josse is an worker of Medical Machine Enterprise Providers, Inc.

1. Buckland, Aaron J. MBBS, FRACS, Ethan W. Ayres, MPH, Andrew J. Shimmin, MBBS, FRACS, Jonathan V. Naked, MBBS, FRACS, Stephen J. McMahon, MBBS, FRACS, Jonathan M. Vigdorchik, MD. (2019) Prevalence of Sagittal Spinal Deformity Amongst Sufferers Present process Whole Hip Arthroplasty, DOI: 10.1016/j.arth.2019.08.020.
2. D. Novikov, J. J. Mercuri, R. Schwarzkopf, W. J. Lengthy, J. A. Bosco III, J. M. Vigdorchik. Can some early revision whole hip arthroplasties be averted?  Bone Joint J 2019;101-B(6 Supple B):97–103
3. J. Vigdorchik, N. Eftekhary, A. Elbuluk, M. P. Abdel, A. J. Buckland, R. S. Schwarzkopf, S. A. Jerabek, D. J. Mayman.  Analysis of the backbone is crucial within the workup of recurrent instability after whole hip arthroplasty.  Bone Joint J 2019;101-B:817–823.

Cautions Regarding Ahead-Trying Statements

This press launch accommodates “forward-looking statements” as outlined within the Non-public Securities Litigation Reform Act of 1995 relating to CUPTIMIZE Hip-Backbone Evaluation. The reader is cautioned to not depend on these forward-looking statements. These statements are based mostly on present expectations of future occasions. If underlying assumptions show inaccurate or identified or unknown dangers or uncertainties materialize, precise outcomes might range materially from the expectations and projections of DePuy Synthes, Inc, any of the opposite Johnson & Johnson MedTech Firms and/or Johnson & Johnson.  Dangers and uncertainties embrace, however usually are not restricted to: uncertainty of business success; challenges to patents; competitors, together with technological advances, new merchandise and patents attained by opponents; manufacturing difficulties and delays; product efficacy or security considerations leading to product remembers or regulatory motion; modifications to relevant legal guidelines and rules, together with world well being care reforms; modifications in habits and spending patterns of purchasers of well being care services; and traits towards well being care value containment. An extra listing and descriptions of those dangers, uncertainties and different elements might be present in Johnson & Johnson’s Annual Report on Type 10-Ok for the fiscal yr ended January 2, 2022, together with within the sections captioned “Cautionary Observe Concerning Ahead-Trying Statements” and “Merchandise 1A. Danger Elements,” and in Johnson & Johnson’s subsequent Quarterly Studies on Type 10-Q and different filings with the Securities and Change Fee. Copies of those filings can be found on-line at www.sec.gov, www.jnj.com, or on request from Johnson & Johnson. Neither DePuy Synthes, Inc. / the Johnson & Johnson MedTech Firms nor Johnson & Johnson undertakes to replace any forward-looking assertion on account of new info or future occasions or developments.

204539-220317 DSUS
© DePuy Synthes 2022. All rights reserved.
Please discuss with the directions to be used for a whole listing of indications, contraindications, warnings and precautions.